Novel compounds for the treatment and prevention of neurological complications of viral infections
AssigneeSunRegen Healthcare AG
InventorYuhong Dong
Life of this patent
Estimating the term…
Abstract
The present invention relates to a compound of formula (I): as well as a metabolite of the compound of formula (I), pharmaceutical composition comprising the compound of formula (I) or its metabolite, and/or ophioglossum for use in the treatment, prevention and/or alleviation of symptoms of neurological complication(s) of a viral infection disease. The instant compounds, metabolites, pharmaceutical compositions and ophioglossus are particularly useful in the treatment, prevention and/or alleviation of symptoms of neurological complication(s) of a viral infection disease caused by SARS-CoV-2.
Claims22
A method for treating, preventing, or alleviating symptoms of a neurological complication of a viral infection disease comprising administering to a subject in need thereof a pharmaceutically effective amount of a compound of formula (I)
- wherein R1, R2 and R3 are independently selected from H or —C(O)—C14-alkyl, provided that at least one of R1, R2 and R3 is —C(O)—C14-alkyl.
A method for treating, preventing, or alleviating symptoms of a neurological complication of a viral infection disease comprising administering to a subject in need thereof a pharmaceutical effective amount of a metabolite of a compound of formula (I)
- wherein R1, R2 and R3 are independently selected from H or —C(O)—C14-alkyl, provided that at least one of R1, R2 and R3 is —C(O)—C14-alkyl, and the metabolite is HO—C(O)—C14-alkyl or a pharmaceutically acceptable salt thereof.
A method for treating, preventing, or alleviating symptoms of a neurological complication of a viral infection disease comprising administering to a subject in need thereof a pharmaceutically effective amount of Ophioglossum.
Dependencies are inferred from the claim text.